Immunization of mice with cells from juvenile worms of Schistosoma japonicum provides immunoprotection against schistosomiasis

Science in China, Series C: Life Sciences

Volumn 50, Issue 6, 2007, Pages 822-830

  Zeng, TieBing ^a,b   Cai, LiTing ^a   Zeng, QingRen ^a   Yang, ShengHui ^a   Yu, Rong ^a   Li, YanQin ^a   Fang, HuiLong ^a   Li, BenWen ^c   Zhang, ShunKe ^a  

^a Central South University   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c Washington University School of Medicine   (United States)

Author keywords

Cultured cell; Immune response; Immunoprotection; Juvenile worm cell; Schistosoma japonicum

Indexed keywords

ANIMAL; ARTICLE; CELL CULTURE; IMMUNOLOGY; LARVA; MOUSE; REPRODUCIBILITY; SCHISTOSOMA JAPONICUM; VACCINATION;

ANIMALS; CELLS, CULTURED; LARVA; MICE; REPRODUCIBILITY OF RESULTS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; VACCINATION;

MURINAE; MUS; SCHISTOSOMA JAPONICUM;

EID: 36448969005     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-007-0100-7     Document Type: Article

References (38)

1. Bergquist N R, Colley D G. Schistosomiasis vaccines: research to development. Parasitol Today, 1998, 14(3): 99-104
2. Hewitson J P, Hamblin P A, Mountford A P. Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol, 2005, 27(7-8): 271-280
3. Coulson P S. The radiation-attenuated vaccine against schistosomes in animal models: Paradigm for human vaccine? Adv Parasitol, 1997, 39, 271-336
4. Ford M J, Bickle Q D, Taylor M G. Immunization of rats against Schistosoma mansoni using irradiated cercariae, lung schistosomula and liver-stage worms. Parasitology 1984, 89(Pt 2): 327-344
5. James S L, Pearce E J. The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis. J Immunol, 1988, 140(8): 2753-2759
6. Hsü S Y, Hsü H F, Svestka K W, et al. Vaccination against schistosomiasis in mice with killed schistosomula without adjuvant. Proc Soc Exp Biol Med, 1986, 181(3): 454-458
7. Afifi M A, El-Wakil H S, Abdel-Ghaffar M M, et al. Application of adult worm and lung-stage antigens to immunize against Schistosoma mansoni using cytokines as adjuvants. J Egypt Soc Parasitol, 2006, 36(1): 351-362
8. McManus D P, Bartley B P. A vaccine against Asian schistosomiasis. Parasitol Int, 2004, 53(2): 163-173
9. Bergquist R, Al-Sherbiny M, Barakat R, et al. Blueprint for schistosomiasis vaccine development. Acta Trop, 2002, 82(2): 183-192
10. McManus D P. The search for a vaccine against schistosomiasis - a difficult path but an achievable goal. Immunol Rev, 1999, 171: 149-161
11. Zhang Y, Taylor M G, Johansen M V, et al. Vaccination of mice with a cocktail DNA vaccine induces a Th1-type immune response and partial protection against Schistosoma japonicum infection. Vaccine, 2001, 20(5-6): 724-730
12. Wei Y Q, Wang Q R, Zhao X, et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med, 2000, 6(10): 1160-1166
13. Vermorken J B, Claessen A M, van Tinteren H, et al. Active-specific immunotherapy for stage II and stage III human colon cancer: A randomized trial. Lancet, 1999, 353(9150): 345-350
14. Sinkovics J G, Horvath J C. Vaccination against human cancers. Int J Oncol, 2000, 16(1): 81-96.
15. Canthaboo C, Williams L, Xing D K L, et al. Investigation of cellular and humoral immune response to whole cell and acellular pertussis vaccine. Vaccine, 2001, 19(6): 637-643
16. Pace J L, Rossi H A, Esposito V M, et al. Inactivated whole-cell bacterial vaccines: Current status and novel strategies. Vaccine, 1998, 16(16): 1563-1574
17. Armijos R X, Weigel M M, Calvopina M, et al. Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis. Vaccine, 2004, 22(9-10): 1320-1326
18. Zhang Z Y, Li L R. Researches on the cytological prophylaxis and treatment of parasitosis. J Tianjin Agric Coll (in Chinese), 2001, 8(1): 5-8
19. Liu W, Zeng T B, Zeng Q R, et al. Biological identification on sub-cultivation cells of Schistosoma japonicum adult worms in vitro. Chin J Parasitol Parasit Dis (in Chinese), 2006, 24(5): 375-378
20. Zeng Q R, Lin X C, Gong Y F, et al. Study on the protective immunity in mouse induced by a new type of vaccine, live cells of Schistosoma japonicum schistosomulum. Chin J Mod Medic (in Chinese), 2004, 14(14): 84-97
21. Wright M D, Davern K M, Mitchell G F. The functional and immunological significance of some schistosome surface molecules. Parasitol Today, 1991, 7(2): 56-58
22. Smithers S R, Hackett F, Orrier Ali P, et al. Protective immunization of mice against Schistosoma mansoni with purified adult worm surface membranes. Parasite Immunol, 1989, 11(4): 301-318
23. Capron A, Dessaint J P. Molecular basis of host-parasite relationship: Towards the definition of protective antigens. Immunol Rev, 1989, 112: 27-48
24. Willadaen P, Eiseman C H, Tellam R L. 'Concealed' antigens: Expanding the range of immunological targets. Parasitol Today, 1993, 9(4): 132-135
25. Braschi S, Wilson R A. Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics, 2006, 5(2): 347-356
26. Woolhouse M E. A theoretical framework for the immunoepidemiology of blocking antibodies to helminth infection. Parasite Immunol, 1994, 16(8): 415-424
27. Diwan M, Elamanchili P, Cao M, et al. Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery. Curr Drug Deliv, 2004, 1(4): 405-412
28. Telino E, De Luca P M, Matos D C, et al. In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes. Clin Exp Immunol, 2006, 143(2): 338-344
29. Pearce E J, James S L, Dalton J, et al. Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine. J Immunol, 1986, 137(11): 3593-3600.
30. Coulson P S, Mountford A P. Fate of attenuated schistosomula administered to mice by different routes, relative to the immunity induced against Schistosoma mansoni. Parasitology, 1989, 99(Pt 1): 39-45
31. Mountford A P, Harrop R, Wilson R A. Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with attenuated larvae. Infect Immunol, 1995, 63(5): 1980-1986
32. Mountford A P, Harrop R. Vaccination against Schistosomiasis: The case for Lung-stage Antigens. Parasitol Today, 1998, 14(3): 109-114
33. Medley G, Anderson R M. Density-dependent fecundity in Schistosoma mansoni infections in man. Trans R Sot Trap Med Hyg, 1985, 79: 532-534
34. Wilson R A, Coulson P S, Betts C, et al. Impaired immunity and altered pulmonary response in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology, 1996, 87(2): 275-282
35. Jankovic D, Wynn T A, Kullberg M C, et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B celland IFN-gamma-dependent effector mechanisms. J Immunol, 1999, 162(1): 345-351
36. Wynn T A, Hoffmann K F. Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2? Parasitol Today, 2000, 16(11): 497-501
37. Finkelman F D, Holmes J, Katona I M, et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol, 1990, 8: 303-333
38. 4+ T cells. Annu Rev Immunol, 1994, 12(Pt 6): 635-673